Publications

A selection of publications relating to the impact of Australian Stroke Alliance members and organisations.
  • Zhao H, Coote S, Easton D, et al. Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than Thrombolysis. Stroke. 2020;51(3):922‐930
  • Kim, J; Easton, D; Zhao, H; Coote, S; Sookram, G; Smith, K; Stephenson, M; Bernard, S; Parsons, M; Yan, B; Desmond, P; Mitchell, P; Campbell, B; Donnan, G; Davis, S; Cadilhac, D. Economic evaluation of the Melbourne Mobile Stroke Unit. International Journal of Stroke 2020 Jun 14. Online Ahead of print.
  • Zhao H, Coote S, Pesavento L, Jones B, Rodrigues E, Ng JL, et al. Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit. Int J Stroke. 2019 Apr;14(3):265-269.
  • https://www.world-stroke.org/assets/downloads/WSO_Global_Stroke_Fact_Sheet.pdf
  • https://strokefoundation.org.au/About-Stroke/Facts-and-figures-about-stroke#fn4
  • Dwyer M, Rehman S, Ottavi T, Stankovich J, Gall S, Peterson G, et al. Urban-rural differences in the care and outcomes of acute stroke patients: Systematic review. J Neurol Sci. 2019;397:63-74.
  • Gardiner, FW; Bishop, L; Dos Santos, A; Sharma, P; Easton, D; Quinlan, F; Churilov, L; Schwarz, M; Walter, S; Fassbender, K; Davis, S; Donnan, GA. Aeromedical retrieval for stroke in Australia. Cerebrovasc Dis. 2020;49(3):334-340
  • Campbell BCV, De Silva DA, Macleod MR, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019 Oct 10;5(1):70
  • Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612-23.
  • Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008 Apr;7(4):299-309.
  • Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. The New England journal of medicine. 2012;366(12):1099-1107.
  • Campbell B C, Mitchell P J, Kleinig T J, Dewey H M, Churilov L, Yassi N, Yan B, Dowling R J, Parsons M W, Oxley T J, Wu T Y, Brooks M, Simpson M A, Miteff F, Levi C R, Krause M, Harrington T J, Faulder K C, Steinfort B S, Priglinger M., … EXTEND-IA Investigators (2015). Endovascular therapy for ischemic stroke with perfusion-imaging selection. The New England journal of medicine, 372(11), 1009–1018.
  • Campbell BCV, Mitchell PJ, Churilov L…Parsons MW, Donnan GA, Davis SM; EXTEND-IA TNK Investigators. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018 Apr 26;378(17):1573-1582.
  • Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. N Engl J Med. 2019; May 9;380(19):1795‐1803.
  • Campbell BCV, Ma H, Ringleb PA, et al. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet. 2019;394(10193):139‐147
  • Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009 Mar;8(3):261-9.
  • Emberson J, Davis S, Donnan G, Grotta J, Hacke W. Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Version 2. Lancet. 2014 Nov 29;384(9958):1929-35.
  • Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015 Jul;46(7):2032-60.
  • Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66(8):1175-81.
  • Meretoja A, Churilov L, Campbell BC, et al. The spot sign and tranexamic acid on preventing ICH growth–AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial. Int J Stroke. 2014;9(4):519‐24.
  • Goyal M, Donnan GA, Davis SM, Jovin TG; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr 23;387(10029):1723-31.
  • Saver JL, Smith EE, Fonarow GC, et al. The “golden hour” and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke 2010 Jul;41(7):1431-9.
  • Cadilhac DA, Kilkenny MF, Longworth M, Pollack MR, Levi CR; Metropolitan Clinical Taskforce and Stroke Services New South Wales Coordinating Committee. Metropolitan-rural divide for stroke outcomes: do stroke units make a difference?Intern Med J. 2011;41(4):321‐6.
  • Bishop, L., Gardiner, F.W. and Sharma, P. (2019). Time metrics for stroke aeromedical retrievals by the Royal Flying Doctor Service (RFDS): 2014–2018. Canberra: Royal Flying Doctor Service of Australia.
  • Gardiner FW, Coleman M, Teoh N, et al. Aeromedical retrievals of people for mental health care and the low level of clinical support in rural and remote Australia. Med J Aust. 2019;211(8): 351-356.
  • https://www.ambulance.vic.gov.au/about-us/our-services/
  • Walter S, Zhao H, Easton D, Bil C, Sauer J, Liu Y, et al. Air-Mobile Stroke Unit for access to stroke treatment in rural regions. Int J Stroke. 2018;13(6):568-75.
  • Bishop, L., Gardiner, F.W., Sharma, P. and Quinlan, F. (2020). Results of the Royal Flying Doctor Service national stroke survey. Canberra: Royal Flying Doctor Service of Australia
  • Walter S, Kostopoulos P, Haass A, et al. Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol. 2012 May;11(5):397-404.
  • Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL. Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. The Lancet Neurology. 2017;16(3):227-37.
  • Ebinger M, Harmel P, Nolte CH, Grittner U, Siegerink B, Audebert HJ. Berlin prehospital or usual delivery of acute stroke care – Study protocol. Int J Stroke. 2017 Aug;12(6):653-658.
  • Parker SA, Bowry R, Wu TC, et al. Establishing the first mobile stroke unit in the United States. Stroke. 2015;46(5):1384‐
  • Bowry R, Parker S, Rajan SS, et al. Benefits of stroke treatment using a Mobile Stroke Unit compared with standard management: The BEST-MSU Study Run-In Phase. Stroke. 2015 May;46(5):1384-91
  • Shuaib A, Jeerakathil T; Alberta Mobile Stroke Unit Investigators. The mobile stroke unit and management of acute stroke in rural settings. CMAJ 2018 Jul 16;190(28):E855-E858
  • Donnan GA, Davis SM, Parsons MW, Ma H, Dewey HM, Howells DW. How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol. 2011;7(7):400‐9
  • Mobashsher AT, Abbosh AM. On-site Rapid Diagnosis of Intracranial Hematoma using Portable Multi-slice Microwave Imaging System. Nature: Scientific Reports. 2016;6:37620.
  • Alexandrov A, Dusenbury W, Fink M. New Mobile Stroke Unit Programs Aim to Improve Outcomes. ED Manag. 2017;29(1):1‐6
  • Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382(18):1679-1681
  • Bladin CF, Kim J, Bagot KL, et al. Improving acute stroke care in regional hospitals: clinical evaluation of the Victorian Stroke Telemedicine program. Med J Aust. 2020;212(8):371‐377
  • https://strokefoundation.org.au/what-we-do/research/no-postcode-untouched
  • Bivard A, Churilov L. and Parsons M. Artificial Intelligence for decision support in stroke: current role and future potential. Nature Reviews Neurology. 16,575-585(2020)
  • Thrift AG, Cadilhac DA, Eades S. Excess risk of stroke in Australia’s Aboriginal and Torres Strait Islander populations. Stroke. 2011;42(6):1501‐2
  • Katzenellenbogen JM, Vos T, Somerford P, Begg S, Semmens JB, Codde JP. Burden of stroke in indigenous Western Australians: a study using data linkage. Stroke. 2011;42(6):1515‐21
  • Gardiner FW, Johns H, Bishop L, Churilov L. Royal Flying Doctor Service COVID-19 activity and surge modelling in Australia. Air Med J. Sep-Oct 2020;39(5):404-409.
  • Mackay M, Churilov  L, Moon A, McKenzie I, Donnan G,  Monagle  P, Li Q, Babl F.  Identification of barriers and enablers to rapid diagnosis along the paediatric stroke chain of recovery using Value-Focused Process Engineering. Health Systems 2019, 1-16.
  • https://ulurustatement.org/the-statement
  • Eliakundu, A; Cadilhac, D; Kim, J; Andrew, N; Bladin, C; Grimley, R; Dewey, H; Donnan, GA; Hill, K; Levi, CR; Middleton, S: Anderson, C; Lannin, N; Kilkenny, M; behalf of the AuSCR consortium partners and Stroke123 investigators. Factors associated with arrival by ambulance for patients with stroke: a multicentre, national data linkage study. In press
  • Zhao Y, Condon J, Lawton P, He V, Cadilhac DA. Lifetime direct costs of stroke for indigenous patients adjusted for comorbidities. Neurology. 2016;87(5):458‐65
  • Zhao Y, Guthridge S, Falhammar H, Flavell H, Cadilhac DA. Cost-effectiveness of stroke care in Aboriginal and non-Aboriginal patients: an observational cohort study in the Northern Territory of Australia. BMJ Open. 2017 Oct 5;7(10):e015033.
  • Kilkenny M, Churilov L, Cadilhac DA. Risk-adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR). Med J Aust. 2017;207(7):315‐316